Lipocine
LPCN
LPCN
19 hedge funds and large institutions have $29.7M invested in Lipocine in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.6M | |
| 2 | +$621K | |
| 3 | +$552K | |
| 4 |
Renaissance Technologies
New York
|
+$171K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$147K |
Top Sellers
| 1 | -$652K | |
| 2 | -$74.7K | |
| 3 | -$71K | |
| 4 |
Morgan Stanley
New York
|
-$28K |
| 5 |
Citigroup
New York
|
-$26K |